Carol Wilkinson, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Child Language | 1 | 2021 | 61 | 0.810 |
Why?
|
| Fragile X Syndrome | 1 | 2021 | 107 | 0.780 |
Why?
|
| Language Development | 2 | 2021 | 196 | 0.710 |
Why?
|
| Observation | 1 | 2019 | 310 | 0.660 |
Why?
|
| Checklist | 1 | 2019 | 781 | 0.460 |
Why?
|
| Cytoskeletal Proteins | 4 | 2013 | 1421 | 0.420 |
Why?
|
| Developmental Disabilities | 1 | 2019 | 1370 | 0.410 |
Why?
|
| Electroencephalography | 2 | 2021 | 5781 | 0.330 |
Why?
|
| Child Development | 1 | 2019 | 2177 | 0.330 |
Why?
|
| Receptors, AMPA | 3 | 2013 | 346 | 0.280 |
Why?
|
| Brain | 4 | 2021 | 24969 | 0.280 |
Why?
|
| Nerve Tissue Proteins | 4 | 2013 | 4592 | 0.250 |
Why?
|
| Pediatrics | 1 | 2019 | 3554 | 0.250 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2021 | 108 | 0.200 |
Why?
|
| Event-Related Potentials, P300 | 1 | 2021 | 141 | 0.200 |
Why?
|
| Neuronal Plasticity | 4 | 2013 | 1426 | 0.190 |
Why?
|
| Serum Response Factor | 1 | 2009 | 100 | 0.180 |
Why?
|
| Immediate-Early Proteins | 1 | 2009 | 459 | 0.140 |
Why?
|
| RNA Stability | 1 | 2007 | 309 | 0.140 |
Why?
|
| Language Development Disorders | 1 | 2016 | 176 | 0.140 |
Why?
|
| Siblings | 1 | 2019 | 806 | 0.140 |
Why?
|
| Child, Preschool | 4 | 2021 | 41081 | 0.130 |
Why?
|
| Autistic Disorder | 1 | 2021 | 1044 | 0.120 |
Why?
|
| Central Nervous System Stimulants | 1 | 2021 | 1134 | 0.110 |
Why?
|
| Synapses | 1 | 2010 | 1706 | 0.100 |
Why?
|
| Program Evaluation | 1 | 2016 | 2524 | 0.080 |
Why?
|
| Parents | 2 | 2021 | 3154 | 0.080 |
Why?
|
| Risk | 1 | 2019 | 9641 | 0.080 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2021 | 3565 | 0.070 |
Why?
|
| Bicuculline | 2 | 2013 | 101 | 0.070 |
Why?
|
| Sex Factors | 1 | 2019 | 10566 | 0.070 |
Why?
|
| Child | 3 | 2021 | 73636 | 0.060 |
Why?
|
| Cell Nucleus | 1 | 2013 | 3021 | 0.060 |
Why?
|
| Databases, Factual | 1 | 2019 | 7763 | 0.060 |
Why?
|
| Health Promotion | 1 | 2016 | 2172 | 0.060 |
Why?
|
| Neurons | 3 | 2013 | 9385 | 0.060 |
Why?
|
| Infant | 3 | 2021 | 34261 | 0.060 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 13536 | 0.060 |
Why?
|
| Gene Expression | 1 | 2006 | 8014 | 0.060 |
Why?
|
| Gene Expression Regulation | 2 | 2013 | 12447 | 0.060 |
Why?
|
| Homeostasis | 1 | 2013 | 3334 | 0.050 |
Why?
|
| RNA, Messenger | 1 | 2007 | 13314 | 0.050 |
Why?
|
| Telemedicine | 1 | 2016 | 2583 | 0.050 |
Why?
|
| Neuropeptide Y | 1 | 2010 | 200 | 0.050 |
Why?
|
| PC12 Cells | 1 | 2009 | 345 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2009 | 12005 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2021 | 50597 | 0.040 |
Why?
|
| AIDS-Related Complex | 1 | 2007 | 110 | 0.040 |
Why?
|
| San Francisco | 1 | 2016 | 157 | 0.040 |
Why?
|
| GABA Antagonists | 1 | 2006 | 133 | 0.040 |
Why?
|
| Humans | 7 | 2021 | 708843 | 0.040 |
Why?
|
| Rats | 3 | 2013 | 25094 | 0.030 |
Why?
|
| Blotting, Northern | 1 | 2006 | 1636 | 0.030 |
Why?
|
| Male | 4 | 2021 | 349524 | 0.030 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2006 | 461 | 0.030 |
Why?
|
| GABA-A Receptor Antagonists | 1 | 2013 | 63 | 0.030 |
Why?
|
| Nuclear Localization Signals | 1 | 2013 | 84 | 0.030 |
Why?
|
| Rats, Long-Evans | 1 | 2013 | 405 | 0.030 |
Why?
|
| Tetrodotoxin | 1 | 2013 | 257 | 0.030 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2006 | 603 | 0.030 |
Why?
|
| beta-Galactosidase | 1 | 2013 | 623 | 0.030 |
Why?
|
| In Situ Hybridization | 1 | 2006 | 1988 | 0.030 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2013 | 380 | 0.030 |
Why?
|
| Drug Interactions | 1 | 2006 | 1456 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 2009 | 20170 | 0.030 |
Why?
|
| Memory | 1 | 2010 | 2154 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2013 | 589 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2006 | 2877 | 0.020 |
Why?
|
| Animals | 5 | 2013 | 170486 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2006 | 5456 | 0.020 |
Why?
|
| Transfection | 1 | 2006 | 6161 | 0.020 |
Why?
|
| Protein Transport | 1 | 2013 | 2059 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2013 | 1759 | 0.020 |
Why?
|
| Base Sequence | 1 | 2009 | 13352 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2007 | 5525 | 0.020 |
Why?
|
| Mice | 3 | 2013 | 80876 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2009 | 18748 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2010 | 15274 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2006 | 3936 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2016 | 7994 | 0.020 |
Why?
|
| Calcium | 1 | 2006 | 5825 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2021 | 61932 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 11790 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2013 | 9927 | 0.010 |
Why?
|
| Female | 1 | 2019 | 375205 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2006 | 5703 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2013 | 8072 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2013 | 22989 | 0.010 |
Why?
|
| Mutation | 1 | 2013 | 29262 | 0.010 |
Why?
|
| Adult | 1 | 2016 | 211041 | 0.000 |
Why?
|